Trial intelligence / Profile preview

Venofer in Iron Deficient Patients with CKD and Heart Failure

NCT02392910Phase 4Completed

Sponsor
Hospital Alemán
Start
Mar 2006
Primary completion
Feb 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of iron sucrose in iron deficiency anemia (IDA) and anemia, sponsored by Hospital Alemán. Primary endpoint: All-cause Mortality at 5 years. Started Mar 2006; status: completed.

02

Drugs

iron sucrose
03

Conditions

iron deficiency anemia (IDA)anemia

Beyond the preview

Go deeper on NCT02392910.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02392910.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call